News - Berlex Laboratories
By Archer, D F Key words: HORMONE REPLACEMENT THERAPY, DROSPIRENONE, ESTROGEN, PROGESTIN, ESTRADIOL/DROSPIRENONE COMBINATION, MENOPAUSE ABSTRACT The efficacy of estrogen with or without a progestogen as hormone replacement therapy (HRT) for menopausal symptoms is well- established.
Berlex, a US affiliate of Bayer Schering Pharma, has said that the FDA has approved a new indication for Yaz to treat acne in women who desire an oral contraceptive for birth control. The approval makes Yaz the first and only oral contraceptive approved by the FDA for three distinct indications.
WAYNE, N.J., Jan. 29 /PRNewswire/ -- Berlex, Inc., a U.S. affiliate of Bayer Schering Pharma, Germany, announced today that the U.S.
Berlex Oncology, a US affiliate of Schering AG, said that a national clinical study is underway to investigate a new approach to treating a common form of non-Hodgkin's lymphoma.
